Skip to main content

Table 3 ORRs and DCRs of irAEs and no-irAEs groups

From: Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis

irAEs (n = 53)

no-irAEs (n = 42)

P value

n

%

n

%

7

13.2

5

11.9

0.763a

32

60.4

29

69.0

0.381b

  1. Abbreviations: irAEs Immune-related adverse events, ORR Objective response rate, DCR Disease control rate
  2. aContinuity correction; bPearson chi-squared